Product of natural evolution (SARS, MERS, and SARS-CoV-2); deadly diseases, from SARS to SARS-CoV-2

文献类型: 外文期刊

第一作者: Shahrajabian, Mohamad Hesam

作者: Shahrajabian, Mohamad Hesam;Sun, Wenli;Cheng, Qi;Cheng, Qi;Cheng, Qi

作者机构:

关键词: SARS; coronaviruses; SARS-CoV-2; MERS; pneumonia; emerging diseases

期刊名称:HUMAN VACCINES & IMMUNOTHERAPEUTICS ( 影响因子:3.452; 五年影响因子:3.483 )

ISSN: 2164-5515

年卷期:

页码:

收录情况: SCI

摘要: SARS-CoV-2, the virus causing COVID-19, is a single-stranded RNA virus belonging to the order Nidovirales, family Coronaviridae, and subfamily Coronavirinae. SARS-CoV-2 entry to cellsis initiated by the binding of the viral spike protein (S) to its cellular receptor. The roles of S protein in receptor binding and membrane fusion makes it a prominent target for vaccine development. SARS-CoV-2 genome sequence analysis has shown that this virus belongs to the beta-coronavirus genus, which includes Bat SARS-like coronavirus, SARS-CoV and MERS-CoV. A vaccine should induce a balanced immune response to elicit protective immunity. In this review, we compare and contrast these three important CoV diseases and how they inform on vaccine development.

分类号:

  • 相关文献
作者其他论文 更多>>